Dr Robert Wade

Dr Robert Wade is an experienced Consultant Clinical Oncologist who provides expert, comprehensive care for patients facing cancer diagnoses. Known for his professional and reassuring approach, Dr Wade works alongside multidisciplinary clinical teams to deliver thorough, patient-centred care. He is dedicated to helping individuals understand their diagnosis, guiding them through every stage of their treatment pathway, and ensuring that care plans are tailored to each patient's individual needs.

In his clinical practice, Dr Wade focuses primarily on urological malignancies, gynaecological cancers, and germ cell tumours. His sub-speciality interests encompass the management of prostate cancer as well as female reproductive tract cancers, including ovarian, cervical, and endometrial malignancies. He utilises a range of therapeutic modalities, including radiotherapy, systemic chemotherapy, and oral chemotherapy regimens. By combining clinical expertise with clear, empathetic communication, Dr Wade assists patients in making well-informed decisions regarding complex treatment options.

Dr Wade earned his Bachelor of Science (BSc) and Bachelor of Medicine, Bachelor of Surgery (MBBS) degrees before completing extensive postgraduate clinical training. He holds prestigious professional qualifications and memberships, having been admitted as a Member of the Royal College of Physicians (MRCP) and a Fellow of the Royal College of Radiologists (FRCR). His professional background includes comprehensive specialist Registrar training across major NHS teaching hospitals and specialist cancer centres in the United Kingdom.

In addition to his clinical responsibilities, Dr Wade actively contributes to cancer service developments and clinical research initiatives aimed at enhancing therapeutic delivery and patient experience. He maintains a holistic view of patient care, prioritising comfort, clarity, and ongoing support. Outside of his clinical commitments, Dr Wade enjoys walking, gardening, cycling, and ice climbing.